Loading clinical trials...
Loading clinical trials...
The general objective of this project is to evaluate the value of cell-free DNA circulating in plasma as a marker of tumor evolution in patients with high-grade gliomas and meningiomas. To this end, ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
IRCCS San Raffaele
Collaborators
NCT03340506 · Melanoma, Non Small Cell Lung Cancer, and more
NCT05278208 · High Grade Glioma, Meningioma, and more
NCT05212272 · High Grade Glioma
NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more
NCT04655404 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma
IRCCS Ospedale San Raffaele
Milan, MI
Istituto Clinico Humanitas IRCCS
Rozzano, MI
Istituto Oncologico Veneto
Padova, PD
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions